Skip to main content
SpringerLink
Log in

Clinical stage I seminoma: the case for surveillance

  • Review
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

We believe that active surveillance is the optimal choice for compliant men who are able to handle the mental burden of not receiving adjuvant treatment. This takes into consideration the fact that a small number of men with clinical stage I (CSI) seminoma on surveillance will recur but are salvageable with equivalent outcome compared to those having adjuvant treatment which exposes eight in ten men to unnecessary short- and long-term risks with still the possibility of recurrence requiring salvation. This review will focus on CSI seminoma and the controversies surrounding its treatment and based upon current available evidence will outline the case for surveillance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sant M, Aareleid T, Artioli ME et al (2007) Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study. Eur J Cancer 43:585. doi:10.1016/j.ejca.2006.11.006

    Article  PubMed  Google Scholar 

  2. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71. doi:10.3322/CA.2007.0010

    Article  PubMed  Google Scholar 

  3. Martin JM, Panzarella T, Zwahlen DR et al (2007) Evidence-based guidelines for following stage 1 seminoma. Cancer 109:2248. doi:10.1002/cncr.22674

    Article  PubMed  Google Scholar 

  4. Fleshner N, Warde P (2002) Controversies in the management of testicular seminoma. Semin Urol Oncol 20:227. doi:10.1053/suro.2002.36979

    Article  PubMed  Google Scholar 

  5. Samant R, Alomary I, Genest P et al (2008) Contemporary management of stage I testicular seminoma: a survey of Canadian radiation oncologists. Curr Oncol 15:168. doi:10.3747/co.v15i4.213

    Article  PubMed  CAS  Google Scholar 

  6. Groll RJ, Warde P, Jewett MA (2007) A comprehensive systematic review of testicular germ cell tumor surveillance. Crit Rev Oncol Hematol 64:182. doi:10.1016/j.critrevonc.2007.04.014

    Article  PubMed  CAS  Google Scholar 

  7. Bernal F, Raman JD (2008) Exploration of treatment options for the management of stage I testicular seminoma. Expert Rev Anticancer Ther 8:1081. doi:10.1586/14737140.8.7.1081

    Article  PubMed  CAS  Google Scholar 

  8. Albers P (2007) Management of stage I testis cancer. Eur Urol 51:34. doi:10.1016/j.eururo.2006.08.022

    Article  PubMed  Google Scholar 

  9. Chia VM, Li Y, Goldin LR et al (2009) Risk of cancer in first- and second-degree relatives of testicular germ cell tumor cases and controls. Int J Cancer 124:952. doi:10.1002/ijc.23971

    Article  PubMed  CAS  Google Scholar 

  10. Akre O, Pettersson A, Richiardi L (2009) Risk of contralateral testicular cancer among men with unilaterally undescended testis: a meta analysis. Int J Cancer 124:687. doi:10.1002/ijc.23936

    Article  PubMed  CAS  Google Scholar 

  11. Cooper DE, L’Esperance JO, Christman MS et al (2008) Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility. J Urol 180:577. doi:10.1016/j.juro.2008.04.032

    Article  PubMed  Google Scholar 

  12. Laguna M, Klepp O, Horwich A et al (2004) Guidelines on testicular cancer. European Association of Urology (EAV), Arnhem, The Netherlands

  13. Walsh TJ, Croughan MS, Schembri M et al (2009) Increased risk of testicular germ cell cancer among infertile men. Arch Intern Med 169:351. doi:10.1001/archinternmed.2008.562

    Article  PubMed  Google Scholar 

  14. Travis LB, Fossa SD, Schonfeld SJ et al (2005) Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 97:1354

    PubMed  Google Scholar 

  15. Mead GM, Stenning SP (1997) The International Germ Cell Consensus Classification: a new prognostic factor-based staging classification for metastatic germ cell tumours. Clin Oncol (R Coll Radiol) 9:207. doi:10.1016/S0936-6555(97)80001-5

    CAS  Google Scholar 

  16. Krege S, Beyer J, Souchon R et al (2008) European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 53:478. doi:10.1016/j.eururo.2007.12.024

    Article  PubMed  Google Scholar 

  17. Hoffman KE, Chen MH, Punglia RS et al (2008) Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma. J Clin Oncol 26:3937. doi:10.1200/JCO.2008.16.5043

    Article  PubMed  Google Scholar 

  18. Warde P, Specht L, Horwich A et al (2002) Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 20:4448. doi:10.1200/JCO.2002.01.038

    Article  PubMed  Google Scholar 

  19. Krege S, Beyer J, Souchon R et al (2008) European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol 53:497. doi:10.1016/j.eururo.2007.12.025

    Article  PubMed  Google Scholar 

  20. National Comprehensive Cancer Network (2009) The NCCN testicular cancer clinical practice guidelines in oncology, vol. 1. http://www.nccn.org, version 2

  21. Berkmen F, Hizli F (2006) Stage I testicular seminoma: surveillance versus adjuvant radiotherapy. Turk J Cancer 36:169

    Google Scholar 

  22. Rudberg L, Carlsson M, Nilsson S et al (2002) Self-perceived physical, psychologic, and general symptoms in survivors of testicular cancer 3 to 13 years after treatment. Cancer Nurs 25:187. doi:10.1097/00002820-200206000-00003

    Article  PubMed  Google Scholar 

  23. Fossa SD, Abyholm T, Normann N et al (1986) Post-treatment fertility in patients with testicular cancer. III. Influence of radiotherapy in seminoma patients. Br J Urol 58:315. doi:10.1111/j.1464-410X.1986.tb09062.x

    Article  PubMed  CAS  Google Scholar 

  24. Fosså SD, Horwich A, Russell JM et al (1999) Optimal planning target volume for stage I testicular seminoma: a medical research council randomized trial. J Clin Oncol 17:1146

    PubMed  Google Scholar 

  25. Joos H, Sedlmayer F, Gomahr A et al (1997) Endocrine profiles after radiotherapy in stage I seminoma: impact of two different radiation treatment modalities. Radiother Oncol 43:159. doi:10.1016/S0167-8140(97)00052-2

    Article  PubMed  CAS  Google Scholar 

  26. Albers P, Albrecht W, Algaba F et al (2008) Guidelines on testicular cancer. European Association of Urology (EAU), Arnhem, p 54

    Google Scholar 

  27. Jewett MA, Zuniga A (2008) Renal tumor natural history: the rationale and role for active surveillance. Urol Clin North Am 35:627. doi:10.1016/j.ucl.2008.07.004

    Article  PubMed  Google Scholar 

  28. Klotz L (2008) Active surveillance for prostate cancer: trials and tribulations. World J Urol 26:437. doi:10.1007/s00345-008-0330-8

    Article  PubMed  Google Scholar 

  29. Aparicio J, Germa JR, Del Muro XG et al (2005) Risk-adapted management for patients with clinical stage I seminoma: the second Spanish Germ Cell Cancer Cooperative Group study. J Clin Oncol 23:8717. doi:10.1200/JCO.2005.01.9810

    Article  PubMed  Google Scholar 

  30. Loehrer PJ Sr, Bosl GJ (2005) Carboplatin for stage I seminoma and the sword of Damocles. J Clin Oncol 23:8566. doi:10.1200/JCO.2005.03.0361

    Article  PubMed  Google Scholar 

  31. Rochester M, Scurrell S, Parry JR (2008) Prospective evaluation of a novel one-stop testicular clinic. Ann R Coll Surg Engl 90:565. doi:10.1308/003588408X301055

    Article  PubMed  Google Scholar 

  32. Bosl GL, Bajorin DF, Sheinfeld J et al (2000) Cancer of the testis. In: Devita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology. Williams and Wilkins, Lippincott, p 1269

    Google Scholar 

  33. Chung P, Parker C, Panzarella T et al (2002) Surveillance in stage I testicular seminoma—risk of late relapse. Can J Urol 9:1637

    PubMed  CAS  Google Scholar 

  34. Gurkaynak M, Akyol F, Zorlu F et al (2003) Stage I testicular seminoma: para-aortic and iliac irradiation with reduced dose after orchiectomy. Urol Int 71:385. doi:10.1159/000074091

    Article  PubMed  Google Scholar 

  35. Garcia-Serra AM, Zlotecki RA, Morris CG et al (2005) Long-term results of radiotherapy for early-stage testicular seminoma. Am J Clin Oncol Cancer Clin Trials 28:119

    Google Scholar 

  36. Huddart RA, Norman A, Shahidi M et al (2003) Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 21:1513. doi:10.1200/JCO.2003.04.173

    Article  PubMed  CAS  Google Scholar 

  37. Zagars GK, Ballo MT, Lee AK et al (2004) Mortality after cure of testicular seminoma. J Clin Oncol 22:640. doi:10.1200/JCO.2004.05.205

    Article  PubMed  Google Scholar 

  38. Van Den Belt-Dusebout AW, Nuver J, De Wit R et al (2006) Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 24:467. doi:10.1200/JCO.2005.02.7193

    Article  PubMed  Google Scholar 

  39. Horwich A (1994) Mortality and cancer incidence following radiotherapy for seminoma of the testis. Radiother Oncol 30:193. doi:10.1016/0167-8140(94)90457-X

    Article  PubMed  CAS  Google Scholar 

  40. Oliver RTD, Mason MD, Mead GM et al (2005) Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 366:293. doi:10.1016/S0140-6736(05)66984-X

    Article  PubMed  CAS  Google Scholar 

  41. Travis LB, Curtis RE, Storm H et al (1997) Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 89:1429. doi:10.1093/jnci/89.19.1429

    Article  PubMed  CAS  Google Scholar 

  42. Bokemeyer C, Schmoll HJ (1993) Secondary neoplasms following treatment of malignant germ cell tumors. J Clin Oncol 11:1703

    PubMed  CAS  Google Scholar 

  43. Travis LB, Fosså SD, Schonfeld SJ et al (2005) Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 97:1354

    Article  PubMed  Google Scholar 

  44. Van Leeuwen FE, Stiggelbout AM, Van den Belt-Dusebout AW et al (1993) Second cancer risk following testicular cancer: a follow-up study of 1,909 patients. J Clin Oncol 11:415

    PubMed  Google Scholar 

  45. Wanderas EH, Fossa SD, Tretli S (1997) Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients. Eur J Cancer, Pt A 33:253. doi:10.1016/S0959-8049(96)00458-3

    Article  CAS  Google Scholar 

  46. Jones WG, Fossa SD, Mead GM et al (2005) Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). J Clin Oncol 23:1200. doi:10.1200/JCO.2005.08.003

    Article  PubMed  Google Scholar 

  47. Yeoh E, Razali M, O’Brien PC (1993) Radiation therapy for early stage seminoma of the testis. Analysis of survival and gastrointestinal toxicity in patients treated with modern megavoltage techniques over 10 years. Australas Radiol 37:367. doi:10.1111/j.1440-1673.1993.tb00097.x

    Article  PubMed  CAS  Google Scholar 

  48. Schmoll HJ, Souchon R, Krege S et al (2004) European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15:1377. doi:10.1093/annonc/mdh301

    Article  PubMed  CAS  Google Scholar 

  49. Schmoll HJ, Souchon R, Krege S et al (2004) European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15:1377. doi:10.1093/annonc/mdh301

    Article  PubMed  CAS  Google Scholar 

  50. Feldman DR, Bosl GJ (2008) Treatment of stage I seminoma: is it time to change your practice? J Hematol Oncol 1:22. doi:10.1186/1756-8722-1-22

    Article  PubMed  Google Scholar 

  51. Dieckmann KP, Brüggeboes B, Pichlmeier U et al (2000) Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient? Urology 55:102. doi:10.1016/S0090-4295(99)00376-3

    Article  PubMed  CAS  Google Scholar 

  52. Oliver RTD, Edmonds PM, Ong JYH et al (1994) Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy? Int J Radiat Oncol Biol Phys 29:3

    PubMed  CAS  Google Scholar 

  53. Fosså SD, Gilbert E, Dores GM et al (2007) Noncancer causes of death in survivors of testicular cancer. J Natl Cancer Inst 99:533. doi:10.1093/jnci/djk111

    Article  PubMed  Google Scholar 

  54. Loehrer PJ Sr, Bosl GJ (2005) Carboplatin for stage I seminoma and the sword of damocles. J Clin Oncol 23:8566. doi:10.1200/JCO.2005.03.0361

    Article  PubMed  Google Scholar 

  55. Martin JM, Panzarella T, Zwahlen DB et al (2007) Evidence-based guidelines for following stage 1 seminoma. Cancer 109:2248. doi:10.1002/cncr.22674

    Article  PubMed  Google Scholar 

  56. Meinardi MT, Gietema JA, Van Der Graaf WTA et al (2000) Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol 18:1725

    PubMed  CAS  Google Scholar 

  57. Travis LB, Andersson M, Gospodarowicz M et al (2000) Treatment-associated leukemia following testicular cancer. J Natl Cancer Inst 92:1165. doi:10.1093/jnci/92.14.1165

    Article  PubMed  CAS  Google Scholar 

  58. Powles T, Robinson D, Shamash J et al (2008) The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann Oncol 19:443. doi:10.1093/annonc/mdm540

    Article  PubMed  CAS  Google Scholar 

  59. Warde P, Gospodarowicz MK, Panzarella T et al (2000) Long term outcome and cost in the management of stage I testicular seminoma. Can J Urol 7:967

    PubMed  CAS  Google Scholar 

  60. Rustin GJ, Mead GM, Stenning SP et al (2007) Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: medical research council trial TE08, ISRCTN56475197—The National Cancer Research Institute Testis Cancer Clinical Studies Group. J Clin Oncol 25:1310. doi:10.1200/JCO.2006.08.4889

    Article  PubMed  Google Scholar 

  61. Choo R, Thomas G, Woo T et al (2005) Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma. Int J Radiat Oncol Biol Phys 61:736

    PubMed  Google Scholar 

  62. Bauduceau O, Souleau B, Le-Moulec S et al (2003) Radiotherapy in stage I testicular seminoma: retrospective study and review of literature. Cancer Radiother 7:386

    PubMed  CAS  Google Scholar 

  63. Daugaard G, Petersen PM, Rørth M et al (2003) Surveillance in stage I testicular cancer. APMIS 111:76

    Article  PubMed  Google Scholar 

  64. Parker C, Milosevic M, Panzarella T et al (2002) The prognostic significance of the tumour infiltrating lymphocyte count in stage I testicular seminoma managed by surveillance. Eur J Cancer 38:2014

    PubMed  CAS  Google Scholar 

  65. Aparicio J, García del Muro X, Maroto P et al (2003) Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. Ann Oncol 14:867

    Article  PubMed  CAS  Google Scholar 

  66. Porcaro AB, Antoniolli SZ, Schiavone D et al (2002) Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature. Arch Ital Urol Androl 74:77

    PubMed  Google Scholar 

  67. Francis R, Bower M, Brunström G et al (2000) Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options. Eur J Cancer 36:1925

    Article  PubMed  CAS  Google Scholar 

  68. Jones A, Fergus JN, Chapman J et al (1999) Is surveillance for stage 1 germ cell tumours of the testis appropriate outside a specialist centre? BJU Int 84:79

    Article  PubMed  CAS  Google Scholar 

  69. Coleman JM, Coleman RE, Turner AR et al (1998) The management and clinical course of testicular seminoma: 15 years' experience at a single institution. Clin Oncol (R Coll Radiol) 10:237

    CAS  Google Scholar 

  70. Germa Lluch JR, Climent MA, Villavicencio H et al (1993) Treatment of stage I testicular tumours. Br J Urol 71:473

    Article  PubMed  CAS  Google Scholar 

  71. Von Der Maase H, Specht L, Jacobsen GK et al (1993) Surveillance following orchidectomy for stage I seminoma of the testis. Eur J Cancer Part A: General Topics 29:1931

    Google Scholar 

  72. Thomas GM (1993) Surveillance in stage I seminoma of the testis. Urol Clin North Am 20:85

    PubMed  CAS  Google Scholar 

  73. Ramakrishnan S, Champion AE, Dorreen MS et al (1992) Stage I seminoma of the testis: is post-orchidectomy surveillance a safe alternative to routine postoperative radiotherapy? Clin Oncol (R Coll Radiol) 4:284

    CAS  Google Scholar 

  74. Horwich A, Alsanjari N, Hern RA et al (1992) Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer 65:775

    PubMed  CAS  Google Scholar 

  75. Allhoff EP, Liedke S, De Riese W et al (1991) Stage I seminoma of the testis. Adjuvant radiotherapy or surveillance? Br J Urol 68:190

    Article  PubMed  CAS  Google Scholar 

  76. Duchesne GM, Horwich A, Dearnaley DP et al (1990) Orchidectomy alone for stage I seminoma of the testis. Cancer 65:1115

    Article  PubMed  CAS  Google Scholar 

  77. Charig MJ, Hindley AC, Lloyd K et al (1990) 'Watch policy' in patients with suspected stage I testicular seminoma: CT as a sole staging and surveillance technique. Clin Radiol 42:40

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Urology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

    Nathan Lawrentschuk & Neil Fleshner

Authors
  1. Nathan Lawrentschuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Neil Fleshner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nathan Lawrentschuk.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lawrentschuk, N., Fleshner, N. Clinical stage I seminoma: the case for surveillance. World J Urol 27, 433–439 (2009). https://doi.org/10.1007/s00345-009-0430-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-009-0430-0

Keywords

Search

Navigation